Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Charles Brenner
University of Iowa, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
ChromaDex, Inc.
Equity Interest - Publicly traded entity (e.g., stock, stock option, or other ownership interest)
Since Dr. Brenner has equity in and receives payment for consulting from the company whose product is being evaluated, and receives royalties from the company for the product being evaluated, bias or influence could be introduced into the research. Based on this analysis, we have determined that the interests could directly and significantly affect the design, conduct, or reporting of the PHS-funded research, or have the appearance of doing so.
Evaluating NAD Supplementation as a Novel Treatment for Arrhythmias
Abnormalities in cardiac sodium channels cause inherited arrhythmias syndromes complicated by sudden death and are present in acquired heart conditions with sudden death such as heart failure. NAD+ and related cellular metabolites important for cellular energy and redox metabolism control posttranslational modifications on the cardiac sodium currents. This application will determine how metabolism alters sodium channel structure and function, and whether manipulation of the NAD+ metabolome can be used to increase sodium currents and prevent arrhythmias.
Filed on May 13, 2019.
Tell us what you know about Charles Brenner's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Charles Brenner filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Charles Brenner | University of Iowa | Conflict of Interest | ChromaDex, Inc. | $20,000 - $39,999 |
| Charles Brenner | University of Iowa | Conflict of Interest | ChromaDex, Inc. | $20,000 - $39,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.